Akshay Girish Shahapurkar

Akshay Girish Shahapurkar

Active Director Director DIN 09495518
DIN 09495518 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Girish Shahapurkar

Data last updated:

Akshay Girish Shahapurkar is a Director at Asvinau Pharmavision Private Limited (since 2022). The company operates in Chemicals.

DIN 09495518
Primary Designation Director
Industry Chemicals
First Appointment 07 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asvinau Pharmavision Private Limited U24290PN2022PTC208333
Director07 Feb 20222022Active

Board colleagues of Akshay Girish Shahapurkar

Directorship timeline

Open interactive timeline →
Asvinau Pharmavision Private Limited
Premium access

Shareholding and investment profile for Akshay Girish Shahapurkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Girish Shahapurkar

Akshay Girish Shahapurkar currently holds 1 directorship: Asvinau Pharmavision Private Limited (Director, since 07 Feb 2022).

Akshay Girish Shahapurkar was first appointed on 07 Feb 2022 as Director at Asvinau Pharmavision Private Limited.

The current boards of Akshay Girish Shahapurkar's companies include Pradip Baban Bhintade (Asvinau Pharmavision Private Limited), Vishal Kailas Deshmukh (Asvinau Pharmavision Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available